🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial seeks to find out the best dose and possible side effec...
Status
Active Not Recruiting
Location
Cleveland Clinic
Start Date
2021-11-16
Trial ID
NCT04850495
Treatments Being Tested
This is a prospective, single-center, single-arm, phase II study of Zanubru...
Status
Unknown
Location
Department of Medical Oncology, Sun Yat-sen University Cancer Center
Start Date
2021-01-31
Trial ID
NCT04736914
Treatments Being Tested
This study is a single-arm, open label, non-randomized, phase 2 trial of za...
Status
Recruiting
Location
Virginia Commonwealth University
Start Date
2025-05-27
Trial ID
NCT06846463
Treatments Being Tested
This study aim to evaluate the efficacy and safety of zanubrutinib combined...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2022-11-26
Trial ID
NCT06005870
Treatments Being Tested
This trial is a single-center, single-arm, prospective clinical study to in...
Status
Unknown
Location
The First Hospital of Lanzhou University
Start Date
2022-10-30
Trial ID
NCT05596097
Treatments Being Tested
Non-Hodgkin lymphoma (NHL), with high aggressiveness and mortality, is one ...
Status
Unknown
Location
Department of Hematology, Shandong Provincial Hospital
Start Date
2021-03-01
Trial ID
NCT05164770
This study is a prospective, open-label, single-arm phase II clinical study...
Status
Unknown
Location
Xing Xiaojing
Start Date
2023-08-01
Trial ID
NCT05887726
Treatments Being Tested
This study is a multi-center, open-label, single-arm, non-randomized phase ...
Status
Unknown
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2022-02-01
Trial ID
NCT05200312
Zanubrutinib, as a new generation of BTK inhibitors, has shown more potent ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-06-01
Trial ID
NCT06890585
This is a prospective, single-center, open-label clinical study designed to...
Status
Unknown
Location
First Affiliated Hospital of Wenzhou Medical University
Start Date
2022-06-15
Trial ID
NCT05428670
Treatments Being Tested